anti-Vasohibin 1 (VASH1) Antikörper

Angiogenesis inhibitor. Zusätzlich bieten wir Ihnen Vasohibin 1 Kits (11) und Vasohibin 1 Proteine (5) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
VASH1 22846 Q7L8A9
VASH1 238328 Q8C1W1
VASH1 503052  
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-Vasohibin 1 Antikörper auf antikoerper-online.de

Showing 10 out of 94 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Lieferzeit Preis Details
Rind (Kuh) Kaninchen Unkonjugiert WB WB Suggested Anti-VASH1 Antibody Titration: 0.2-1 ug/mlELISA Titer: 1:312500Positive Control: 721_B cell lysate 100 μL 2 bis 3 Tage
$289.00
Details
Rind (Kuh) Kaninchen Unkonjugiert WB WB Suggested Anti-VASH1 Antibody Titration: 0.2-1 ug/mlELISA Titer: 1:312500Positive Control: 721_B cell lysate 100 μL 2 bis 3 Tage
$289.00
Details
Human Maus Unkonjugiert IHC (p), ELISA, WB VASH1 monoclonal antibody (M05), clone 4A3. Western Blot analysis of VASH1 expression in HepG2. Immunoperoxidase of monoclonal antibody to VASH1 on formalin-fixed paraffin-embedded human salivary gland. [antibody concentration 3 ug/ml] 100 μg 11 bis 12 Tage
$440.00
Details
Human Kaninchen Unkonjugiert ELISA, ICC, IF, WB ABIN6275886 staining COLO205 cells by IF/ICC. The sample were fixed with PFA and permeabilized in 0.1% Triton X-100,then blocked in 10% serum for 45 minutes at 25¡ãC. The primary antibody was diluted at 1/200 and incubated with the sample for 1 hour at 37¡ãC. An  Alexa Fluor 594 conjugated goat anti-rabbit IgG (H+L) antibody(Cat.# S0006), diluted at 1/600, was used as secondary antibod 100 μL 11 bis 12 Tage
$390.77
Details
Human Maus Unkonjugiert ELISA, IHC, IHC (p), WB Human Placenta: Formalin-Fixed, Paraffin-Embedded (FFPE) 50 μg 11 bis 14 Tage
$742.50
Details
Human Kaninchen Unkonjugiert ELISA, IF, IHC, IHC (p), WB Anti-Vasohibin 1 / VASH1 antibody IHC staining of human prostate, ganglion. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. 0.05 mg 11 bis 14 Tage
$484.00
Details
Rind (Kuh) Kaninchen Unkonjugiert WB 100 μL 11 bis 14 Tage
$551.83
Details
Fledermaus Kaninchen Unkonjugiert WB 100 μL 11 bis 14 Tage
$551.83
Details
Human Kaninchen Unkonjugiert IF (p), IHC (p), WB Rat liver lysate probed with Anti VASH1 Polyclonal Antibody, Unconjugated  at 1:3000 for 90 min at 37˚C. Predicted band 41kD. Observed band size: 40kD 100 μL 3 bis 7 Tage
$317.90
Details
Human Kaninchen Unkonjugiert IHC, WB 100 μL 11 bis 13 Tage
$366.77
Details

Am meisten referenzierte anti-Vasohibin 1 Antikörper

  1. Human Monoclonal VASH1 Primary Antibody für IHC (p), ELISA - ABIN524800 : Wang, Tian, Zhang, Wang: Upregulation of vasohibin-1 expression with angiogenesis and poor prognosis of hepatocellular carcinoma after curative surgery. in Medical oncology (Northwood, London, England) 2012 (PubMed)
    Show all 3 Pubmed References

Weitere Antikörper gegen Vasohibin 1 Interaktionspartner

Human Vasohibin 1 (VASH1) Interaktionspartner

  1. The vasohibin1 was identified as the first tubulin-detyrosinating enzyme, A cell-autonomous role for vasohibin1 in regulating the cytoskeleton was unexpected due to their previous association with angiogenesis.

  2. In conclusion, cervical squamous cell carcinoma (CSCC)-secreted exosomal miR-221-3p transfers into HLECs to promote lymphangiogenesis and lymphatic metastasis via downregulation of VASH1 and may represent a novel diagnostic biomarker and therapeutic target for metastatic CSCC patients in early stages

  3. We applied whole-genome sequencing (WGS) on 9 trios where the probands are sporadically affected with the most severe form of the disorder and harbor no coding sequence variants affecting the function of known Hirschsprung disease (HSCR) genes. We found de novo protein-altering variants in three intolerant to change genes-CCT2, VASH1, and CYP26A1-for which a plausible link with the enteric nervous system (ENS) exists

  4. Low VASH1 expression is associated with angiogenesis and tumor growth in renal cell carcinoma.

  5. VASH1 is a prognostic marker in ovarian carcinoma.

  6. VASH1 and VASH2 but not SVBP alone, increased detyrosination of -tubulin, and purified vasohibins removed the C-terminal tyrosine of -tubulin.

  7. High serum prolactin and vasoinhibin levels predict and may impact retinopathy of prematurity progression

  8. Studied angiogenic activity of vasohibin-1 (VASH1), by analyzing levels of VASH1 in both RCC tissue and non-neoplastic kidney tissue. Found elevated VASH1 density, but not microvascular density, was a significant and independent predictor of overall survival in RCC.

  9. identified a novel UPS regulatory system in which essential domain architecture (VASH-PS) of VASHs, comprising regions VASH191-180 and VASH280-169 , regulate the cytosolic punctate structure formation in the absence of SVBP.

  10. replicative senescence, the downregulation of VASH1 expression in endothelial cells was caused, at least in part, by the alteration of microRNA expression.

  11. VASH1 expression is associated with tumour progression and may be useful as a prognostic marker of head and neck squamous cell carcinoma

  12. VASH1 expression inhibited tumor vascularization and growth, not only in high VEGF-producing cells, but also in high PDGF-producing cells, reduced their peritoneal dissemination and ascites, and prolonged the survival time of the host

  13. in this study, the length of tube forming structures of endothelial cells in vitro showed that Vasohibin-1 expression in gastric cancer cells significantly decreased the ability of vessel formation of endothelium cells.

  14. These results indicate that cancer cells proteolytically inactivate VASH1 protein secreted by ECs in the tumour microenvironment

  15. Our present findings on VASH1A and VASH1B should provide an innovative approach that would improve the efficacy of antiangiogenic cancer therapy by balancing vascular normalization and pruning.

  16. VASH1 exerts an antitumor effect on ovarian cancer by inhibiting angiogenesis in the tumor environment

  17. VASH1 expression levels in atheroma reflects both enhanced neovascularization and the inflammatory burden

  18. Knockdown of VASH1 in cancer cells promoted cell growth, adhesion and migration in vitro, and enhanced tumorigenesis and metastasis in vivo.

  19. VASH1 and VASH2 showed distinctive localization and opposing function on the fetoplacental vascularization.

  20. These results suggest that the renal levels of VASH-1 may be affected by local inflammation, crescentic lesions and VEGFR-2.

Mouse (Murine) Vasohibin 1 (VASH1) Interaktionspartner

  1. replicative senescence, the downregulation of VASH1 expression in endothelial cells was caused, at least in part, by the alteration of microRNA expression.

  2. These results indicate that cancer cells proteolytically inactivate VASH1 protein secreted by ECs in the tumour microenvironment

  3. Unaffected fibrosis and angiogenesis seen by knocking out endogenous vasohibin-1.

  4. endogenous VASH1 may regulate the development of diabetic renal alterations

  5. VASH1 and VASH2 showed distinctive localization and opposing function on the fetoplacental vascularization.

  6. PKCdelta deficiency enhances neointimal formation, which is associated with delayed reendothelialization and involves increased cellular vasohibin-1 accumulation.

  7. vasohibin1 is the first known intrinsic factor having broad-spectrum antilymphangiogenic activity

  8. data support the hypothesis that vasohibin acts as a negative feedback regulator of neovascularization in the retina and suggest that suppression of VEGF receptor 2 may play some role in mediating its activity

  9. vasohibin has an activity to prevent neointimal formation by inhibiting adventitial angiogenesis

  10. These results suggest a role for VASH1 in negative feedback regulation of haematopoietic progenitors proliferation during recovery following bone marrow ablation.

  11. Loss of vasohibin-1 is associated with persistent angiogenesis in the termination zone of endothelial cells.

  12. These results suggest that endogenous vasohibin-1 is involved in tumor angiogenesis and exogenous vasohibin-1 blocks sprouting angiogenesis by tumors, matures the remaining vessels, and enhances the antitumor effect of conventional chemotherapy

  13. Overexpression of murine VASH1 inhibited angiogenic sprouting and supports vascular maturation processes in vivo.

Cow (Bovine) Vasohibin 1 (VASH1) Interaktionspartner

  1. results demonstrate expression of VASH1, especially in blood vascular endothelial cells in the corpus luteum (CL) and show VASH1 inhibits VEGFA-stimulated capillary like-tube formation by luteal endothelial cells and lymphatic endothelial cells vitro; results indicate VASH1 may act as a negative feedback regulator of angiogenesis and lymphangiogenesis in the CL

Vasohibin 1 (VASH1) Antigen-Profil

Protein Überblick

Angiogenesis inhibitor. Inhibits migration, proliferation and network formation by endothelial cells as well as angiogenesis. This inhibitory effect is selective to endothelial cells as it does not affect the migration of smooth muscle cells or fibroblasts. Does not affect the proliferation of cancer cells in vitro, but inhibits tumor growth and tumor angiogenesis. Acts in an autocrine manner. Inhibits artery neointimal formation and macrophage infiltration. Exhibits heparin-binding activity.

Genbezeichner und Symbole assoziert mit anti-Vasohibin 1 (VASH1) Antikörper

  • vasohibin 1 (VASH1) Antikörper
  • vasohibin 1 (vash1) Antikörper
  • vasohibin 1 (Vash1) Antikörper
  • AI834978 Antikörper
  • D930046M13Rik Antikörper
  • G630009D10Rik Antikörper
  • KIAA1036 Antikörper
  • RGD1564082 Antikörper

Bezeichner auf Proteinebene für anti-Vasohibin 1 (VASH1) Antikörper

vasohibin 1 , vasohibin-1-like , vasohibin-1

GENE ID SPEZIES
100051887 Equus caballus
423369 Gallus gallus
467514 Pan troglodytes
703906 Macaca mulatta
100216209 Xenopus (Silurana) tropicalis
100358035 Oryctolagus cuniculus
100397672 Callithrix jacchus
100435809 Pongo abelii
22846 Homo sapiens
238328 Mus musculus
503052 Rattus norvegicus
490799 Canis lupus familiaris
615419 Bos taurus
100511141 Sus scrofa
Ausgewählte Anbieter für anti-Vasohibin 1 (VASH1) Antikörper
Haben Sie etwas anderes gesucht?